Therapeutic-dose anticoagulation benefits moderately ill COVID-19 patients

By | August 21, 2021
Moderately ill patients hospitalized with COVID-19 have better chances of survival if treated with therapeutic-dose anticoagulation, according to an international study involving 121 sites, including UT Southwestern Medical Center.